The sulfamide motif in the design of enzyme inhibitors

被引:78
|
作者
Winum, JY
Scozzafava, A
Montero, JL
Supuran, CT
机构
[1] Univ Montpellier 2, Lab Chim Biomol, UMR 5032, Ecole Natl Super Chim Montpellier, F-34296 Montpellier, France
[2] Univ Florence, Dipartimento Chim, Chim Bioorgan Lab, I-50019 Sesto Fiorentino, Firenze, Italy
关键词
gamma-secretase; carbonic anhydrase inhibitor; carboxypepridase A; chymase; elastase; enzyme-inhibitor adduct; HIV protease; matrix metalloproteinase; protease inhibitor; protein tyrosine phosphatase; steroid sulfatase inhibitor; sulfamide; thrombin; tryptase;
D O I
10.1517/13543776.16.1.27
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The sulfamide moiety, similarly to the structurally related sulfonamide and sulfamate ones, is widely employed in medicinal chemistry for the design of biologically active compounds. Amongst the enzymes for which sulfamide-based inhibitors were designed are the carbonic anhydrases (CAs), and a large number of proteases belonging to the aspartic protease (HIV-1 protease, gamma-secretase), serine protease (elastase, chymase, tryptase and thrombin, among others) and metalloproteinase (carboxypeptidase A [CPA] and matrix metalloproteinase [MMP]) families. Some steroid sulfatase (STS) and protein tyrosine phosphatase inhibitors belonging to the sulfamide class of derivatives have also been reported. In all these compounds, many of which show low nanomolar affinity for the target enzymes for which they have been designed, the free or substituted sulfamide moiety plays an important role in the binding of the inhibitor to the active site cavity. This is achieved either by directly coordinating to the metal ion found in some metalloenzymes (CAs, CPA, STS), usually by means of one of the nitrogen atoms present in the sulfamide motif, or, as in the case of the cyclic sulfamides, acting as HIV protease inhibitors interacting with the catalytically critical aspartic acid residues of the active site by means of an oxygen atom belonging to the HN-SO2-NH motif that substitutes a catalytically essential water molecule. In other cases, the sulfamide moiety is important for inducing desired physicochemical properties to the drug-like compounds incorporating it, such as enhanced water solubility, better bioavailability etc., due to the intrinsic properties of this highly polarised moiety when attached to an organic scaffold. This interesting motif is, thus, of great value for the design of pharmacological agents with many applications.
引用
收藏
页码:27 / 47
页数:21
相关论文
共 50 条
  • [41] HISTORY OF THE DESIGN OF CAPTOPRIL AND RELATED INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME
    CUSHMAN, DW
    ONDETTI, MA
    HYPERTENSION, 1991, 17 (04) : 589 - 592
  • [42] DEVELOPMENT AND DESIGN OF SPECIFIC INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME
    CUSHMAN, DW
    CHEUNG, HS
    SABO, EF
    ONDETTI, MA
    AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (06): : 1390 - 1394
  • [43] Design of novel inhibitors for the catechol-O-methyltransferase enzyme
    Cook, Emma
    Peterson, Larryn
    Cafiero, Mauricio
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [44] Design of inhibitors of the human immunodeficiency virus (HIV) integrase enzyme
    Griffith, Renate
    Gordon, Christopher P.
    Keller, Paul A.
    DRUGS OF THE FUTURE, 2007, 32 : 28 - 28
  • [45] ADVANCES IN COMPUTER-AIDED-DESIGN OF ENZYME-INHIBITORS
    KUNTZ, ID
    MENG, EC
    SHOICHET, BK
    BODIAN, DL
    ROE, DC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 6 - MEDI
  • [46] De novo design of enzyme inhibitors by growing and scoring with BOMB
    Jorgensen, William L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 29 - 29
  • [47] Integration of methods in cheminformatics and biocalorimetry for the design of trypanosomatid enzyme inhibitors
    Prokopczyk, Igor M.
    Ribeiro, Jean F. R.
    Sartori, Geraldo R.
    Sesti-Costa, Renata
    Silva, Joao S.
    Freitas, Renato F.
    Leitao, Andrei
    Montanari, Carlos A.
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (01) : 17 - 33
  • [48] Design and synthesis of potent, selective inhibitors of endothelin converting enzyme
    Jeng, AY
    Savage, P
    Chou, M
    Trapani, AJ
    Moliterni, JA
    Moskal, MA
    Neubert, AD
    Marcopulos, N
    Stamford, LB
    Wallace, EM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R215 - R215
  • [49] Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif
    Perry, PJ
    Gowan, SM
    Read, MA
    Kelland, LR
    Neidle, S
    ANTI-CANCER DRUG DESIGN, 1999, 14 (04): : 373 - 382
  • [50] Protein Kinase Inhibitor Design by Targeting the Asp-Phe-Gly (DFG) Motif: The Role of the DFG Motif in the Design of Epidermal Growth Factor Receptor Inhibitors
    Peng, Yi-Hui
    Shiao, Hui-Yi
    Tu, Chih-Hsiang
    Liu, Pang-Min
    Hsu, John Tsu-An
    Amancha, Prashanth Kumar
    Wu, Jian-Sung
    Coumar, Mohane Selvaraj
    Chen, Chun-Hwa
    Wang, Sing-Yi
    Lin, Wen-Hsing
    Sun, Hsu-Yi
    Chao, Yu-Sheng
    Lyu, Ping-Chiang
    Hsieh, Hsing-Pang
    Wu, Su-Ying
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (10) : 3889 - 3903